Skip to the page

Data / Drug companies / Apotex Corp.

Apotex Corp.: 357 products in the FDA NDC directory, labeler code 60505

Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).

Apotex Corp. (labeler code 60505) lists 357 products in the FDA National Drug Code Directory, covering 132 finished drugs by generic name. By type: 348 prescription drugs, 7 over the counter drugs. Its main marketing category is generic drugs (ANDA). The newest product started marketing on October 10, 2026.

The request: Watch Apotex Corp. (FDA labeler code 60505): each new product listing and each discontinued product. $10 of work on sign-up, no card.

SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.

Labeler code
60505
Products in commercial distribution
357
Packages
577
Finished drugs by generic name
132
Prescription products
348
Over the counter products
7
Controlled substance products
Schedule II 7, Schedule IV 14, Schedule V 5
Flagged as original packager
196 of 196 products that carry the flag
Started marketing in the last 12 months
45
Products with a marketing end date set
16
Earliest marketing start
July 6, 1997
openFDA record search
api.fda.gov

Products by marketing category

Share of the company's products in commercial distribution.

Marketing categoryProductsShare
Generic drugs (ANDA)33493.6%
New drug applications (NDA)164.5%
Authorized generics (NDA)41.1%
Drugs for further processing30.8%

Products by type

TypeProductsShare
Prescription drugs34897.5%
Over the counter drugs72%
Drugs for further processing20.6%

Drugs it lists

Finished drugs by generic name, with how many companies list each.

DrugProductsCompanies listing it
Paroxetine hydrochloride1416
Olanzapine1049
Tolvaptan99
Amlodipine and atorvastatin89
Sotalol hydrochloride725
Lisdexamfetamine dimesylate716
Atomoxetine hydrochloride78
Dexamethasone745
Dasatinib618
Lenalidomide619
Cefepime66
Cefazolin611
Cyclosporine624
Varenicline511
Brivaracetam517
Ceftriaxone sodium512
Trazodone hydrochloride439
Carbamazepine452
Guanfacine433
Pomalidomide412
Ceftaroline fosamil42
Piperacillin and tazobactam413
Pravastatin sodium439
Atorvastatin calcium459
Omeprazole4106
Modafinil425
Doxazosin428
Armodafinil412
Etodolac431
Ziprasidone hcl46
Eslicarbazepine acetate410
Diltiazem hydrochloride355
Fluvoxamine maleate316
Levetiracetam387
Oxcarbazepine346
Dabigatran etexilate317
Tofacitinib323
Mirtazapine342
Nilotinib310
Olopatadine hydrochloride335
Midodrine hydrochloride334
Tizanidine hydrochloride325
Prasugrel310
Clorazepate dipotassium38
Desmopressin acetate327
Lamivudine314
Acyclovir370
Fluticasone propionate371
Sitagliptin38
Vilazodone hydrochloride313
Risedronate sodium39
Glipizide239
Ipratropium bromide223
Leflunomide219
Triamterene and hydrochlorothiazide227
Deferoxamine mesylate26
Bupropion hydrochloride267
Clopidogrel bisulfate231
Fenofibrate256
Celecoxib263
Solifenacin succinate222
Ondansetron252
Irinotecan hydrochloride212
Selegiline hydrochloride212
Tizanidine238
Regadenoson214
Palonosetron hydrochloride211
Mycophenolic acid216
Ticagrelor232
Abiraterone acetate222
Dapagliflozin226
Ertapenem sodium211
Sitagliptin and metformin hydrochloride28
Prucalopride218
Ofloxacin226
Brimonidine tartrate215
Azelastine hydrochloride217
Imatinib mesylate217
Tetrabenazine212
Ambrisentan213
Pirfenidone226
Nintedanib211
Cilostazol210
Oxaliplatin216
Eribulin mesylate217
Zinc sulfate injection21
Fingolimod118
Pazopanib16
Teriparatide17
Diclofenac sodium1109
Moxifloxacin119
Butorphanol tartrate15
Icosapent ethyl121
Macitentan115
Sirolimus122
Cetrorelix acetate for injection12
Travoprost14
Bromfenac sodium17
Bortezomib126
Budesonide140

Dosage forms

Dosage formProductsShare
Tablet8724.4%
Tablet, film coated7521%
Capsule4913.7%
Injection, powder, for solution215.9%
Spray, metered133.6%
Kit133.6%
Injection, solution123.4%
Injection, powder, lyophilized, for solution113.1%
Injection113.1%
Tablet, film coated, extended release102.8%
Solution/ drops102.8%
Tablet, extended release92.5%

Pharmacologic classes

FDA established pharmacologic classes of its products.

Newest products

By marketing start date.

ProductProduct NDCDosage formMarketing categoryMarketing start
Norethindrone and ethinyl estradiol60505-4901KitGeneric drugs (ANDA)October 10, 2026
Ertapenem60505-4956InjectionGeneric drugs (ANDA)October 1, 2026
Ceftaroline Fosamil60505-4947Injection, powder, lyophilized, for solutionGeneric drugs (ANDA)September 30, 2026
Ceftaroline Fosamil60505-4946Injection, powder, lyophilized, for solutionGeneric drugs (ANDA)September 30, 2026
Ondansetron60505-4939InjectionGeneric drugs (ANDA)September 29, 2026
Tolvaptan60505-4804KitGeneric drugs (ANDA)August 6, 2026
Tolvaptan60505-4803KitGeneric drugs (ANDA)August 6, 2026
Tolvaptan60505-4802KitGeneric drugs (ANDA)August 6, 2026
Tolvaptan60505-4801KitGeneric drugs (ANDA)August 6, 2026
Tolvaptan60505-4800KitGeneric drugs (ANDA)August 6, 2026
Tolvaptan60505-4782TabletGeneric drugs (ANDA)August 6, 2026
Tolvaptan60505-4781TabletGeneric drugs (ANDA)August 6, 2026
Multiple Vitamins (Pediatric) Pharmacy Bulk Package60505-6171KitGeneric drugs (ANDA)July 1, 2026
Evdi60505-6423Injection, solution, concentrateNew drug applications (NDA)June 30, 2026
Multiple Vitamins (Pediatric) Single Dose Vial60505-6190KitGeneric drugs (ANDA)June 24, 2026
Hydrocortisone sodium succinate60505-6411Injection, powder, for solutionGeneric drugs (ANDA)June 19, 2026
Macitentan60505-4644Tablet, film coatedGeneric drugs (ANDA)June 11, 2026
Multiple Vitamins (Adult) Pharmacy Bulk Package60505-6191KitGeneric drugs (ANDA)June 4, 2026
Multiple Vitamins (Adult) Single Dose60505-6172KitGeneric drugs (ANDA)June 4, 2026
Tofacitinib60505-6264Tablet, film coatedGeneric drugs (ANDA)June 3, 2026
Tofacitinib60505-6263Tablet, film coatedGeneric drugs (ANDA)June 3, 2026
Tofacitinib60505-4858Tablet, film coated, extended releaseGeneric drugs (ANDA)June 3, 2026
Sitagliptin and Metformin Hydrochloride60505-3659Tablet, film coatedGeneric drugs (ANDA)May 28, 2026
Sitagliptin and Metformin Hydrochloride60505-3658Tablet, film coatedGeneric drugs (ANDA)May 28, 2026
Sitagliptin60505-3645Tablet, film coatedGeneric drugs (ANDA)May 28, 2026

CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.